Company Description
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States.
The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds, including equine care.
It also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services.
In addition, the company offers hospitals which provides preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services.
Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.
| Country | United States |
| Founded | 2020 |
| IPO Date | Aug 30, 2023 |
| Industry | Personal Services |
| Sector | Consumer Discretionary |
| Employees | 113 |
| CEO | Kimball Carr |
Contact Details
Address: 780 Lynnhaven Parkway, Suite 400 Virginia Beach, Virginia 23452 United States | |
| Phone | 757 734 5464 |
| Website | inspirevet.com |
Stock Details
| Ticker Symbol | IVP |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001939365 |
| CUSIP Number | 45784E106 |
| ISIN Number | US45784E3045 |
| Employer ID | 85-4359258 |
| SIC Code | 0700 |
Key Executives
| Name | Position |
|---|---|
| Kimball Carr | Chairman, Chief Executive Officer and President |
| Richard Paul Frank | Chief Financial Officer |
| Laura Johnson | Vice President of Operations |
| Lynley Kees | Chief People Officer |
| Dr. Alexandra Quatri | Vice President of Medical Operations |
| Debbe Bastian | Financial Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 24, 2025 | ARS | Filing |
| Oct 24, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 24, 2025 | DEF 14A | Other definitive proxy statements |
| Oct 21, 2025 | 8-K | Current Report |
| Oct 6, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Oct 3, 2025 | 424B3 | Prospectus |
| Sep 26, 2025 | EFFECT | Notice of Effectiveness |
| Sep 19, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Sep 15, 2025 | 8-K | Current Report |
| Sep 2, 2025 | 8-K | Current Report |